LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,750,166 | -2.7% | 1,872,118 | 0.0% | 0.93% | +42.9% |
| Q2 2023 | $129,232,306 | +35.7% | 1,872,118 | -5.2% | 0.65% | +5.3% |
| Q1 2023 | $95,264,927 | +79.9% | 1,975,631 | +86.2% | 0.62% | +46.7% |
| Q4 2022 | $52,958,481 | +23.1% | 1,060,867 | +0.6% | 0.42% | +54.0% |
| Q3 2022 | $43,004,000 | +36.2% | 1,054,017 | +83.6% | 0.27% | +48.1% |
| Q2 2022 | $31,575,000 | +131.8% | 574,087 | +53.1% | 0.18% | +203.3% |
| Q1 2022 | $13,623,000 | – | 374,870 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |